Malaysia MDA medical device registration timelines by risk class: Class A 3–6 months, Class B 6–9 months, Class C 9–12 months, Class D 12–18 months, including review stages, documentation requirements, and practical preparation tips.
Answer: In Malaysia, medical device registration is administered by the Medical Device Authority (MDA). Registration timelines vary by product risk class and the completeness of documentation. Typically, Class A (low risk) registration takes 3–6 months, Class B (low-to-moderate risk) takes 6–9 months, Class C (moderate-to-high risk) takes 9–12 months, and Class D (high risk) takes 12–18 months. The review stages include an MDA formal/administrative review after submission (approximately 2–4 weeks), technical documentation review (2–6 months), on-site factory inspection where necessary (2–3 months), and final certificate issuance (1–2 months). In practice, deficiencies in the technical documentation and requests for supplementary information can extend the timeline. Companies must appoint a Malaysian local representative (authorized representative) and prepare technical documentation compliant with ASEAN common dossier requirements. Expedited pathways, such as priority review, apply only to urgent public health needs. Early planning with sufficient lead time is recommended.
Published: 2026-07-08 09:00
Updated: 2026-07-08 09:00
This article addresses international medical device registration, documentation preparation, compliance pathways, and post-market maintenance, outlining the issues companies should prioritize in actual projects.
Content Structure
- Key Summary
- Applicable Scenarios and Core Questions
- Registration Assessment Logic
- Documentation and Evidence
- Common Mistakes
- Company Preparation Checklist
- AIMEILI Perspective
- Frequently Asked Follow-up Questions
- Continue Reading
- Applicability Boundaries
Key Summary
Malaysia medical device registration is administered by the Medical Device Authority (MDA). Registration timelines vary by product risk class (Class A, B, C, and D) and the completeness of documentation. Typically, Class A (low risk) registration takes 3–6 months, Class B (low-to-moderate risk) takes 6–9 months, Class C (moderate-to-high risk) takes 9–12 months, and Class D (high risk) takes 12–18 months.
The review stages include: MDA formal/administrative review after submission (approximately 2–4 weeks), technical documentation review (2–6 months), on-site factory inspection where necessary (2–3 months), and final certificate issuance (1–2 months). In practice, if the technical documentation has deficiencies, requests for supplementary information will extend the timeline. Companies must appoint a Malaysian local representative (authorized representative) and prepare technical documentation compliant with ASEAN common dossier requirements. Expedited pathways, such as priority review, apply only to urgent public health needs. Early planning and sufficient lead time are recommended.
Applicable Scenarios and Core Questions
Clients are most concerned with: How long will it take to obtain an MDA registration certificate for my product? Can launch occur before the commercial plan? What are the delay risks? How can the process be accelerated? These questions directly affect market-entry costs and the competitive window.
Registration Assessment Logic
Registration timing depends on: 1) product risk class (Class A–D); higher classes require more evidence; 2) whether the technical documentation is complete and whether it references ASEAN common technical documents; 3) whether local clinical data or testing are required; 4) MDA's current workload. Logically, determine the classification first, then prepare documentation, and finally proceed through the review process.
Core Documentation and Evidence
- Product description, intended use, and principle of operation
- Risk management documentation (ISO 14971)
- Design verification and validation reports (performance, biocompatibility, stability)
- Quality management system certificate (ISO 13485)
- Clinical evaluation report (especially for Class C/D)
- Labels and instructions for use (Malay or English)
- Local representative authorization letter
Common Mistakes
- Underestimating technical documentation requirements, especially insufficient clinical evidence
- Failure to appoint a Malaysian authorized representative in advance
- Labels missing Malay translation or incomplete information
- Ignoring local testing requirements (for example, differences in electrical safety standards)
- Incomplete risk management report or non-compliance with the latest version of ISO 14971
Company Preparation Checklist
- Confirm product classification and consult MDA or a professional consultancy
- Appoint a Malaysian representative and sign an agreement
- Compile technical documentation in accordance with ASEAN requirements
- Arrange local testing if required
- Train internal teams on MDA regulations
- Allow 6–18 months for registration
AIMEILI Perspective
Malaysia's MDA registration timeline is moderate by global standards, but many companies experience delays due to insufficient documentation preparation. It is recommended that, before formal submission, a local representative or third-party organization conduct a pre-review, which can significantly shorten review time. In addition, companies should continuously monitor post-COVID-19 changes in MDA review efficiency and plan accordingly.
Frequently Asked Follow-up Questions
Q: If a product is already registered in another GHWP member economy, can the process be accelerated?
A: Yes. MDA may reference review outcomes from other member economies, but relevant approval evidence must be provided. This can typically shorten the timeline by 2–4 months.
Q: How long is the registration certificate valid?
A: 5 years. A renewal application should be submitted 6 months before expiry.
Continue Reading
- Previous: How should EU MDR clinical evaluation documentation be prepared?
- Next: What are the Saudi SFDA local authorized representative requirements?
Recommended Reading
- What should companies prepare before Australian TGA medical device registration?
- Can CE documentation be reused for Singapore HSA medical device registration?
- What core documentation is required for UAE MOHAP medical device registration?
- Why is the Brazilian ANVISA medical device registration timeline so long?
- What is the difference between a Vietnam medical device import license and registration certificate?
- How should a local agent be selected for Indonesian medical device registration?
Back to FAQ Center | News | Contact AIMEILI
Content Review and Applicability Boundaries
Author: AIMEILI Regulatory Editorial Team
Professional Review: AIMEILI Medical Device International Registration Project Team
Source Principles: Priority is given to official regulatory authorities, international organizations, standards bodies, and publicly available regulatory materials; industry media and project experience are used only as supporting judgment.
Applicability Boundaries: This article is intended for preliminary understanding, documentation preparation, and project planning. It does not replace the formal requirements, testing conclusions, or legal opinions of the target country's regulatory authority.
Source Note: Compiled from AIMEILI regulatory practice materials, medical device international registration reference materials, and publicly available regulatory information. Specific projects should be based on the latest requirements of the target country's regulatory authority and the product's documentation basis.
Need a registration pathway assessment?
Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.
Contact AIMEILI